Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

CRISPR Therapeutics AG - Common Shares (NQ:CRSP)

49.46 +1.04 (+2.15%)
Streaming Delayed Price Updated: 12:43 PM EDT, Mar 17, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about CRISPR Therapeutics AG - Common Shares

< Previous 1 2
...
16 17 18 19 20 21 22 23 24
...
35 36 Next >
News headline image
The 3 Most Undervalued Cathie Wood Stocks to Buy Now: August 2023 ↗
Even if Cathie Wood stocks in ARK fell from grace, these three portfolio picks remain undervalued and ideal investments. 
Via InvestorPlace
News headline image
What 13 Analyst Ratings Have To Say About CRISPR Therapeutics ↗
 
Via Benzinga
News headline image
Missed Out on CRISPR Therapeutics? My Best Biotech Stock to Buy and Hold ↗
CRISPR Therapeutics is an intriguing biotech stock to consider now. 
Via The Motley Fool
News headline image
3 Reasons to Buy CRISPR Therapeutics Stock, and 1 Reason to Sell ↗
This company is in a critical period, and it could soon grow significantly. 
Via The Motley Fool
News headline image
Ready to Buy the Dip? CRISPR Therapeutics Stock Is a Smart Buy ↗
Its shares tumbled due to factors outside its control, but the biotech still has substantial long-term potential. 
Via The Motley Fool
News headline image
Cathie Wood Buys Roblox, Palantir Dips — Ark Invest Seizes Buying Opportunities Following Earnings Reports ↗
 
Via Benzinga
News headline image
Why CRISPR Therapeutics Stock Is Jumping Today ↗
Analysts continue to like this gene-editing stock. 
Via The Motley Fool
News headline image
1 No-Brainer Cathie Wood Stock to Buy Hand Over Fist in August ↗
Crispr Therapeutics could be incredibly undervalued right now. 
Via The Motley Fool
News headline image
The Latest Analyst Ratings for CRISPR Therapeutics ↗
 
Via Benzinga
News headline image
The 3 Best Biotech Stocks to Buy in August ↗
Even as healthcare stocks suffer from post-pandemic fatigue, these three of the best biotech stocks to buy and ride the wave of good news. 
Via InvestorPlace
News headline image
2 Supercharged Growth Stocks That Could Make You Richer ↗
These two biotechs are poised for a sustained period of growth. 
Via The Motley Fool
News headline image
2 Great Stocks Under $100 to Buy and Hold for 10 Years ↗
Neither has performed well over the past year, but investors would do well to focus on the longer term. 
Via The Motley Fool
News headline image
Fox, Warner Music, Eli Lilly, Chegg And Other Big Stocks Moving Higher On Tuesday ↗
U.S. stocks traded lower, with the Dow Jones falling around 400 points on Tuesday. Here are some big stocks recording gains in today’s session. Paymentus Holdings, Inc. (NYSE: PAY) shares rose 29.4% to... 
Via Benzinga
News headline image
2 Magnificient Growth Stocks to Buy in July ↗
These two growth stocks might be incredibly undervalued right now. 
Via The Motley Fool
News headline image
Why Energizer Holdings Shares Are Trading Lower By 13%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗
Gainers Nuburu, Inc. (NYSE: BURU) shares jumped 185.6% to $1.6593 after the company announced contract with NASA to demonstrate feasibility of power beaming in space using the company’s blue laser... 
Via Benzinga
News headline image
3 Biotech Stocks That Analysts Are Drooling Over ↗
With the medical science realm representing one of the most complex markets, these top analyst biotech picks can be worth your time. 
Via InvestorPlace
News headline image
3 ‘Strong Buy’ Biotech Stocks You Should Be Loading Up On Now ↗
Biotech stocks can be a lucrative investment opportunity, these three biotech stocks to buy now are among analyst favorites. 
Via InvestorPlace
News headline image
Vertex Pharma Raises Annual Forecast On Strong Uptake For Cystic Fibrosis Drug, Analysts Says Investors' Focus On Non-CF Pipeline ↗
Vertex Pharmaceuticals Inc's (NASDAQ: VRTX) Q2 sales increased 14% to $2.49 billion, beating the consensus of $2.41 bill 
Via Benzinga
News headline image
3 Hidden Penny Stocks That Could Turn $100 into $10,000 ↗
These penny stocks have multibagger upside potential with great margins of safety, according to Wall Street analysts. 
Via InvestorPlace
News headline image
These 2 Stocks Are Heading for a Big Moment. Time to Buy? ↗
Both stocks have climbed in the double digits this year. 
Via The Motley Fool
News headline image
This 1 Innovation Could Make These 2 Biotechs Soar by 2030 ↗
Simplifying the cell therapy manufacturing process could be worth a lot of money. 
Via The Motley Fool
News headline image
2 Soaring Stocks With More Upside Potential ↗
Are these mid-cap stocks giants in the making? 
Via The Motley Fool
News headline image
Is Now a Good Time to Buy CRISPR Therapeutics? ↗
CRISPR shares have climbed more than 40% this year. 
Via The Motley Fool
News headline image
3 Tech Stocks to Watch for Groundbreaking Innovations in 2030 ↗
If you’re a speculative investor here are three companies that are on the leading edge of what may be groundbreaking innovations by 2030. 
Via InvestorPlace
News headline image
2 Monster Stocks to Buy Without Any Hesitation ↗
These players each bring in billions of dollars in earnings every year. 
Via The Motley Fool
News headline image
Cathie Wood Is Buying These 3 Growth Stocks Hand Over Fist. Should You? ↗
The captain of innovation-focused investing can't seem to get enough of these beaten-down growth stocks. 
Via The Motley Fool
News headline image
3 Pharma Stocks That AI is Loving in July ↗
Artificial intelligence recommends that these are the three stocks to consider when investing in pharma stocks. 
Via InvestorPlace
News headline image
2 No-Brainer Healthcare Stocks to Buy With $100 Right Now ↗
These stocks may not stay this low for long. 
Via The Motley Fool
News headline image
3 Top Biotech Stocks Defying the Bear Market ↗
Each has the potential to dramatically outperform the market. 
Via The Motley Fool
News headline image
3 Biotech Stocks to Buy for Long-Term Gains
The biotech sector is one of the most volatile sectors, but here are three biotech stocks that offer opportunities for patient biotech stock investors. 
Via MarketBeat
Topics ETFs Economy
< Previous 1 2
...
16 17 18 19 20 21 22 23 24
...
35 36 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.